MicroRNA-200c Attenuates Periodontitis by Modulating Proinflammatory and Osteoclastogenic Mediators

Area of Science:

• Periodontology
• Molecular Biology
• Biomedical Engineering

Background:

• Periodontitis involves inflammation and alveolar bone resorption.
• MicroRNAs (miRNAs) play roles in regulating inflammatory and bone remodeling processes.
• miR-200c's potential therapeutic role in periodontitis requires investigation.

Purpose of the Study:

• To investigate the therapeutic potential of microRNA (miR)-200c in attenuating inflammation and alveolar bone resorption in periodontitis.
• To evaluate the effects of miR-200c overexpression on inflammatory and osteoclastogenic mediators in human gingival fibroblasts (HGFs) challenged with Porphyromonas gingivalis lipopolysaccharide (LPS-PG).
• To assess the efficacy of local miR-200c delivery in a rat model of periodontitis.

Main Methods:

• In vitro study using primary HGFs transfected with miR-200c using polyethylenimine (PEI).
• In vivo study using a rat model of periodontitis induced by LPS injection.
• Local delivery of miR-200c via PEI-plasmid nanoplexes.
• Analysis of inflammatory mediators (IL-6, IL-8, IFRD1, p65, p50), osteoclastogenic factors (RANKL/OPG ratio), micro-computed tomography, and histomorphometry.

Main Results:

• Overexpression of miR-200c in HGFs reduced IL-6, IL-8, IFRD1, p65, and p50 expression following LPS-PG challenge.
• Local injection of miR-200c in rats significantly upregulated gingival miR-200c expression.
• miR-200c treatment reduced IL-6, IL-8, IFRD1, and the RANKL/OPG ratio, and effectively protected against alveolar bone resorption in the rat model.

Conclusions:

• miR-200c effectively suppresses inflammatory and osteoclastogenic mediators in periodontitis.
• Local delivery of miR-200c demonstrates therapeutic potential in preventing periodontitis-associated alveolar bone loss.
• miR-200c represents a promising therapeutic agent for periodontitis management.